Standout Papers

Cannabinoids for Medical Use 2015 2026 2018 2022 1.4k
  1. Cannabinoids for Medical Use (2015)
    Penny Whiting, Robert Wolff et al. JAMA
  2. PROBAST: A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies (2018)
    Robert Wolff, Karel G.M. Moons et al. Annals of Internal Medicine
  3. PROBAST: A Tool to Assess Risk of Bias and Applicability of Prediction Model Studies: Explanation and Elaboration (2018)
    Karel G.M. Moons, Robert Wolff et al. Annals of Internal Medicine
  4. Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients (2015)
    Alfonso Iorio, F.A. Spencer et al. BMJ

Immediate Impact

6 from Science/Nature 57 standout
Sub-graph 1 of 21

Citing Papers

Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2025 Standout
From geroscience to precision geromedicine: Understanding and managing aging
2025 Standout
2 intermediate papers

Works of Robert Wolff being referenced

PROBAST: A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies
2018 Standout
Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients
2015 Standout

Author Peers

Author Last Decade Papers Cites
Robert Wolff 834 621 961 1450 1004 94 6.2k
Víctor Abraira 1160 718 1616 1407 678 140 6.7k
Jeffrey L. Jackson 685 550 1368 1019 1097 171 9.4k
Shelley Hurwitz 902 581 1377 636 914 159 7.6k
Dimitris Mavridis 871 420 1483 655 1030 163 8.9k
Rob Scholten 955 810 2888 1404 1346 96 9.0k
Lori Lyn Price 623 474 2074 813 1263 247 8.7k
Tracy Dana 624 476 895 1664 676 74 6.0k
Alfonso Muriel 880 497 1600 901 1334 262 7.0k
Martin Hellmich 1193 809 1556 1298 1002 404 9.3k
Clifton O. Bingham 683 1972 1113 1376 886 272 11.1k

All Works

Loading papers...

Rankless by CCL
2026